News
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q3 Earnings
Sweetgreen, Inc. (SG) reported $172.39 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 0.6%. EPS of -$0.27 for the same period compares to -$0.18 a
Take-Two Interactive (TTWO) Q2 Earnings and Revenues Beat Estimates
Take-Two Interactive (TTWO) came out with quarterly earnings of $1.46 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.66 per share a year ago
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates
10x Genomics (TXG) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago. These figures are
National Health Investors (NHI) Tops Q3 FFO and Revenue Estimates
National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.32 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to FFO of $1.03 per
Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates
Nektar Therapeutics (NKTR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $2.85. This compares to a loss of $2.7 per share a year ago. These
Universal Display Corp. (OLED) Lags Q3 Earnings and Revenue Estimates
Universal Display Corp. (OLED) came out with quarterly earnings of $0.92 per share, missing the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.4 per share a year ago
JFrog Ltd. (FROG) Surpasses Q3 Earnings and Revenue Estimates
JFrog Ltd. (FROG) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.15 per share a year ago. These figures
Astrana Health, Inc. (ASTH) Misses Q3 Earnings Estimates
Astrana Health, Inc. (ASTH) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.33 per share a year ago
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.96 per share a year
Affirm Holdings (AFRM) Surpasses Q1 Earnings and Revenue Estimates
Affirm Holdings (AFRM) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to a loss of $0.31 per share a year ago. These
Nerdy Inc. (NRDY) Reports Q3 Loss, Lags Revenue Estimates
Nerdy Inc. (NRDY) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.14 per share a year ago. These figures are
Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates
Natera (NTRA) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.26 per share a year ago. These figures are
On Holding (ONON) Suffers a Larger Drop Than the General Market: Key Insights
On Holding (ONON) ended the recent trading session at $35.51, demonstrating a -1.58% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 1.12%. Meanwhile
Genpact (G) Q3 Earnings and Revenues Top Estimates
Genpact (G) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.85 per share a year ago. These figures are
3 Small AI Stocks Ready to Explode (All Under $20)
If you’ve ever wished you’d caught the internet boom early—or owned shares of a company like NVIDIA (NASDAQ: NVDA) before it became a $5 trillion tech behemoth—this one’s for you.
Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates
Mettler-Toledo (MTD) came out with quarterly earnings of $11.15 per share, beating the Zacks Consensus Estimate of $10.62 per share. This compares to earnings of $10.21 per share a year ago. These
Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
Prothena (PRTA) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $1.1 per share a year ago. These figures are
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates
Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.54 per share a year ago. These
Drilling Tools International Corp. (DTI) Tops Q3 Earnings and Revenue Estimates
Drilling Tools International Corp. (DTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.14
IREN Limited (IREN) Reports Q1 Loss, Beats Revenue Estimates
IREN Limited (IREN) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of $0.14. This compares to a loss of $0.22 per share a year ago. These figures are adjusted
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV) ended the recent trading session at $291.21, demonstrating a -1.37% change from the preceding day's closing price. This change lagged the S&P 500's 1.12% loss on the day
Fidelity National Financial (FNF) Q3 Earnings and Revenues Top Estimates
Fidelity National Financial (FNF) came out with quarterly earnings of $1.63 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.3 per share a year
HireQuest, Inc. (HQI) Surpasses Q3 Earnings and Revenue Estimates
HireQuest, Inc. (HQI) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.2 per share a year ago. These
AerSale Corporation (ASLE) Misses Q3 Earnings and Revenue Estimates
AerSale Corporation (ASLE) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.04 per share a year ago. These
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates
AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.17 per share a year ago. These


